The Journal of Heart and Lung Transplantation
Volume 27, Issue 7 , Pages 741-745 , July 2008

No Association Between Single Nucleotide Polymorphisms and the Development of Nephrotoxicity After Orthotopic Heart Transplantation

Received 31 October 2007 ,Revised 31 January 2008 ,Accepted 3 April 2008.

References 

  1. Bloom RD, Doyle AM. Kidney disease after heart and lung transplantation. Am J Transplant. 2006;6:671–679
  2. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report—2005. J Heart Lung Transplant. 2005;24:945–955
  3. Tambur AR, Pamboukian S, Costanzo MR, et al. Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy. J Heart Lung Transplant. 2006;25:690–698
  4. Thervet E, Anglicheau D, King B, et al. Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients. Transplantation. 2003;76:1233–1235
  5. Kalow W, Tang BK, Endrenyi L. Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research. Pharmacogenetics. 1998;8:283–289
  6. Anglicheau D, Legendre C, Thervet E. Pharmacogenetics in solid organ transplantation: present knowledge and future perspectives. Transplantation. 2004;78:311–315
  7. Lindahl GE, Chambers RC, Papakrivopoulou J, et al. Activation of fibroblast procollagen alpha 1(I) transcription by mechanical strain is transforming growth factor-beta-dependent and involves increased binding of CCAAT-binding factor (CBF/NF-Y) at the proximal promoter. J Biol Chem. 2002;277:6153–6161
  8. Kitamura M, Suto T. TGF-beta and glomerulonephritis: anti-inflammatory versus prosclerotic actions. Nephrol Dial Transplant. 1997;12:669–679
  9. Chowbay B, Cumaraswamy S, Cheung Y, Zhou Q, Lee E. Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients. Pharmacogenetics. 2003;13:89–95
  10. Anglicheau D, Verstuyft C, Laurent-Puig P, et al. Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients. J Am Soc Nephrol. 2003;14:1889–1896
  11. Zheng H, Webber S, Zeevi A, et al. Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms. Am J Transplant. 2003;3:477–483
  12. Yamauchi A, Ieiri I, Kataoka Y, et al. Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene. Transplantation. 2002;74:571–572
  13. Baan CC, Balk AH, Holweg CT, et al. Renal failure after clinical heart transplantation is associated with the TGF-beta 1 codon 10 gene polymorphism. J Heart Lung Transplant. 2000;19:866–872
  14. Lacha J, Hubacek JA, Viklicky O, et al. TGF-beta1 gene polymorphism is a risk factor for renal dysfunction in heart transplant recipients. Transplant Proc. 2001;33:1567–1569
  15. Milting H, Lukas N, Klauke B, et al. Composite polymorphisms in the ryanodine receptor 2 gene associated with arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Res. 2006;71:496–505
  16. Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T. Human P-glycoprotein transports cyclosporin A and FK506. J Biol Chem. 1993;268:6077–6080
  17. Kim R, Leake B, Choo E, et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther. 2001;70:189–199
  18. Hebert MF, Dowling AL, Gierwatowski C, et al. Association between ABCB1 (multidrug resistance transporter) genotype and post–liver transplantation renal dysfunction in patients receiving calcineurin inhibitors. Pharmacogenetics. 2003;13:661–674
  19. Kuehl P, Zhang J, Lin Y, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet. 2001;27:383–391
  20. Grinyo J, Cruzado J. Cyclosporine nephrotoxicity. Transplant Proc. 2004;36(suppl):240S–2
  21. Brogan IJ, Pravica V, Hutchinson IV. Genetic conservation of the immunophilin-binding domains of human calcineurin A1 and A2. Transplant Immunol. 2000;8:139–141

 Supported by a grant from Novartis Pharma GmbH (Nürnberg, Germany) and the Erich and Hanna Klessmann Foundation, Gütersloh, Germany.

PII: S1053-2498(08)00288-X

doi: 10.1016/j.healun.2008.04.001

The Journal of Heart and Lung Transplantation
Volume 27, Issue 7 , Pages 741-745 , July 2008

Article Tools